BioDatomics provides powerful yet intuitive bioinformatics analysis software and services that improve genomic and biomedical research productivity. The company's BioDT platform, which was built by some of the world's most experienced computational and molecular biologists, allows researchers and bioinformaticians to more quickly glean insights from their data thanks to an easier-to-use intuitive interface, dramatically reduced analysis turnaround times and real-time collaboration between colleagues. The result is accelerated development of new medical treatments and other breakthroughs. BioDatomics was co-founded by Maxim Mikheev, MD, PhD and local executives Anthony Millin and Alan Taffel, and is headquartered in Bethesda, MD.
Date | Amount | Type | Investors | Valuation |
---|---|---|---|---|
04/22/14 | undisclosed |
Maryland Venture Fund | undisclosed |